Why Is Novo Nordisk Stock Down in 2025, and Is It a Buying Opportunity?

By Parkev Tatevosian, CFA – Sep 30, 2025 at 6:30AM

NYSE: NVO

Novo Nordisk

Market Cap

$187B

Today's Change

(0.01%) $0.01

Current Price

$55.51

Price as of September 30, 2025, 3:58 p.m. ET

Political pressure on Big Pharma is one reason why the industry is underperforming in 2025.

Novo Nordisk (NVO 0.01%) stock investors are eagerly awaiting the potential launch of its weight loss treatment in oral form.

*Stock prices used were the afternoon prices of Sept. 25, 2025. The video was published on Sept. 27, 2025.

About the Author

A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.

TMFParkev

@TMFParkev

Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Novo Nordisk. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services